Ondansetron

Product NDC
68083-114
11-digit product format
680830114
Labeler code
68083
Product ID
68083-114_2f33d54b-c852-4bca-ab80-a2852c1be9b8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ondansetron
Dosage form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Gland Pharma Limited
Application
ANDA090648
Marketing category
ANDA
Marketing start
2012-06-15
Substance
ONDANSETRON HYDROCHLORIDE
Active strength
2 mg/mL
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ondansetron
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ONDANSETRON HYDROCHLORIDE2 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiNMH84OZK2B
Rxcui283504

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d9bd4853-037c-6968-f4d4-9bb9a0efd1eaProduct name220250722
32e23bc9-ce14-4555-bb6d-bcb654d7d296Product name120201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49Product name120201015
909480fe-0d18-c1c1-a658-0bd9a7131822Product name520170829
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68083-114-01Ondansetron20 mL in 1 VIALINJECTION208
68083-114-01Ondansetron1 in 1 CARTONINJECTION18

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ONDANSETRON HYDROCHLORIDEACTIVE INGREDIENTNMH84OZK2BONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRONDANSETRON INJECTION [GLAND PHARMA LIMITED ]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68083-114ONDANSETRON INJECTION [GLAND PHARMA LIMITED]7Current NDC, Legacy NDC, 2 package rows20220324_35716914-ac73-43c0-9aa0-09c99211d941.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
283504ondansetron 2 MG/ML Injectable SolutionPSN35716914-ac73-43c0-9aa0-09c99211d9418
283504ondansetron 2 MG/ML Injectable SolutionSCD35716914-ac73-43c0-9aa0-09c99211d9418
283504ondansetron (as ondansetron HCl ) 2 MG/ML Injectable SolutionSY35716914-ac73-43c0-9aa0-09c99211d9418

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68083-114-01680830114011 VIAL in 1 CARTON (68083-114-01) / 20 mL in 1 VIAL1 vial2012-06-150000-00-00NoNoCurrent